PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
S. birrea significantly reduces blood glucose levels in diabetic animal models [PMID:39590851]; stem-bark aqueous extract produced dose-dependent reductions in blood glucose in diabetic rats [PMID:14692729].
Marula leaf extract (MLE) inhibits hepatic steatosis in obese db/db mice [PMID:35409465].
Marula nut oil was evaluated for safety (irritancy potential) and efficacy in moisturizing, hydrating, and occlusivity [PMID:26528587].
Stem bark methanol extract inhibited the production of nitrite, TNF, IL-1beta, IL-6, and IL-12p40 in macrophages [PMID:20377995].
Ethanolic and aqueous extracts combined with doxorubicin showed activity against drug-resistant HCT15 cells [PMID:39677854].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35409465 (2022) — Sclerocarya birrea (Marula) Extract Inhibits Hepatic Steatosis in db/db Mice. · International journal of environmental research and public health
- 2.PMID: 40041496 (2025) — Marula [Sclerocarya birrea (A. Rich.) Hochst.] products as a food and medicine. · Frontiers in pharmacology
- 3.PMID: 26528587 (2015) — Safety and efficacy of Sclerocarya birrea (A.Rich.) Hochst (Marula) oil: A clinical perspective. · Journal of ethnopharmacology
- 4.PMID: 36268477 (2022) — Nutritional and Phytochemical Variation of Marula (Sclerocarya birrea) (Subspecies caffra and birrea) Fruit among Nine International Provenances Tested in Malawi. · International journal of food science
- 5.PMID: 39045603 (2024)